This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Granulomas  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 100 words of the full text and any section headings.

In reply

We thank Kreuter and colleagues for their letter and review of their own experiences. The varying responses of different patients support a role for tumor necrosis factor in GA. Perhaps this situation may be similar to multiple sclerosis, in which immunomodulators may help a patient with the disease but induce symptoms of demyelination in people who do not have the disease. Until additional patients with GA are treated with etanercept, no definitive conclusion can be reached.

AUTHOR INFORMATION
Correspondence: Dr Shupack, Department of Dermatology, New York University School of Medicine, 530 First Ave, New York, NY 10016-6402 (shupaj01@med.nyu.edu).

Jerome L. Shupack, MD; Kimberly Siu, MD

Arch Dermatol. 2006;142:1237.

RELATED ARTICLE

Failure of Etanercept Therapy in Disseminated Granuloma Annulare
Alexander Kreuter, Peter Altmeyer, and Thilo Gambichler
Arch Dermatol. 2006;142(9):1236-1237.
EXTRACT | FULL TEXT